Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› IGHMBP2
IGHMBP2
(1 companies · 1 programs)
Companies with an active program directed at IGHMBP2.
Vanda Pharmaceuticals Inc.
VNDA
VCA-894A
— Charcot-Marie-Tooth Disease Type 2S
Phase 1